🇺🇸

US SEC Filing Intelligence

· daily

US SEC Trading Suspension Halt Orders — August 11, 2026

Both filings in this stream highlight acute regulatory distress for small-cap companies facing delisting from major US exchanges. Grove Collaborative Holdings, Inc. received an NYSE non-compliance notice for failing to meet minimum market capitalization and stockholders' equity thresholds, a clear negative signal with high materiality (9/10). Hoth Therapeutics, Inc. (now Rocket One Inc.) faces a Nasdaq delisting notice while simultaneously announcing a strategic pivot to AI and space computing, creating a mixed sentiment (6/10) scenario. Neither filing provides period-over-period financial comparisons, insider trading data, or forward-looking guidance, limiting trend analysis. The overarching theme is the precarious financial health of micro-cap issuers, where regulatory non-compliance triggers existential risks. No portfolio-level patterns or sector themes emerge beyond the individual company distress signals.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 11, 2026

This digest of 40 filings reveals a period of significant leadership transition across US equities, with 15+ officer and director changes announced on a single day (August 11, 2026). The most critical developments include a major CEO succession at ConocoPhillips (a 42-year veteran retiring), a pending merger vote at Apogee Therapeutics (shareholders rejected advisory compensation despite approving the AbbVie deal), and a CFO departure at Kilroy Realty creating interim uncertainty. Period-over-period data from the enriched filings shows a stark divergence: industrial and energy companies (Smart Sand, ConocoPhillips) are demonstrating strong operational momentum, while healthcare and tech firms (Aura Biosciences, Mineralys Therapeutics, Inuvo) are reporting widening losses and restructuring. A notable pattern is the prevalence of 'mixed' sentiment in filings with both positive catalysts (e.g., Phase 3 trial enrollment, new product launches) and negative financials (e.g., net losses, cash burn), suggesting the market is pricing in binary outcomes. Insider activity is limited in this batch, but the compensation-linked equity awards at Imunon and Lee Enterprises signal management alignment. The overarching theme is a market in transition, with companies aggressively reshaping leadership and capital structures to navigate a challenging macro environment.

40 high priority 40 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 11, 2026

The 40 filings reveal a significant wave of board and C-suite changes across US equities, with a notable concentration of CFO departures and CEO successions signaling strategic pivots or transitions. Key themes include a 'changing of the guard' at industrial and energy giants like ConocoPhillips and Matthews International, alongside several CFO resignations at mid-cap firms (Kilroy Realty, NRC Health, NeoGenomics) creating temporary leadership vacuums. Financially, the data shows a stark divergence: Smart Sand posted record revenue (+34% YoY) and swung to profitability, while JBS N.V. reported a net loss swing of -$630M despite 14% revenue growth, highlighting margin compression in protein. Insider activity is limited but notable, with the CEO of Imunon electing to take up to 50% of salary in stock, a bullish signal of alignment. The most critical development is the impending AbbVie-Apogee merger closure, which will trigger the resignation of Apogee's entire board, and the upcoming PDUFA date for Mineralys Therapeutics' lorundrostat (Dec 22, 2026), a binary catalyst. Portfolio-level patterns include a defensive shift in compensation structures (Thryv's Bridge Plan, Twin Disc's amended plan) and a trend of appointing former CEOs from other public companies to boards (Group 1 Auto, Hartford, ManpowerGroup), suggesting a focus on operational expertise over financial engineering.

40 high priority 40 total filings
· daily

USA Insider Trading Pulse — August 11, 2026

The August 11, 2026 insider trading pulse reveals a pronounced bearish tilt among high-conviction corporate insiders, with several C-suite executives and directors executing significant sales. The most notable transactions include the CEO of Popular Inc. selling $6.14M in stock, the CEO of Crocs unloading $1.33M, and the Chairman/CEO of ResMed selling $1.03M under a 10b5-1 plan. A concerning cluster of sales is emerging in the Chinese ADR/education technology sector, where a director of New Oriental Education sold $3.24M and the CEO of 17 Education made a small, symbolic buy. On the bullish side, insider buying is sparse but notable, with the CEO of Nano-X Imaging making a small open-market purchase and a director of NVR making a $405K investment at a high per-share price, signaling confidence. A recurring pattern of low-materiality, neutral filings from MFS closed-end funds and a few non-retrievable filings (W&T Offshore, Capstone Holding) dilute the overall signal density but do not alter the primary bearish sentiment. The aggregate data suggests that while the market may be near highs, corporate insiders are taking profits, particularly in financials, consumer discretionary, and select tech names.

47 high priority 3 medium 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 11, 2026

The August 11, 2026 M&A digest reveals a bifurcated market: high-conviction, transformative mergers (Katapult's $4B+ revenue combination) and strategic divestitures (Duos Technologies, Bluerock Homes) are contrasted by early-stage SPAC activity (ARC Group's $105M IPO) and low-materiality corporate actions (East West Ave unit separation). Period-over-period data from the enriched filings shows a clear trend of companies shedding non-core assets to refocus on higher-growth verticals, with Duos and Bluerock both executing portfolio rationalizations. Insider activity is a critical signal—the Duos related-party sale to an interim CFO's entity raises governance flags, while the Katapult merger's 80% dilution to existing holders signals a severe value transfer. No forward-looking guidance was provided in any filing, but the scheduled events (e.g., Katapult's Q3 2026 earnings reflecting the merger) create a catalyst calendar. Capital allocation patterns are mixed: Bluerock is monetizing assets for cash, while ARC Group is deploying IPO proceeds into a trust for future M&A. The overarching theme is capital reallocation—companies are actively reshaping their portfolios, creating both risks (dilution, related-party conflicts) and opportunities (pure-play exposure, post-merger synergies).

6 high priority 6 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 11, 2026

This morning's 50 filings present a bifurcated market landscape. A dominant theme is the concentrated, passive accumulation of shares in a single micro-cap, Park Ha Biological Technology, by six separate entities, collectively amassing over 56% of the diluted float, signaling a potential strategic play or a prelude to a corporate action. This is contrasted by significant insider selling, with a director at Spyre Therapeutics cashing out over $1M in a 10b5-1 plan and a 10% owner at Ramaco Resources liquidating a $4.8M stake. The healthcare sector shows a mixed picture: while Aptevo Therapeutics saw broad-based insider option exercises (a neutral-to-bullish signal of confidence), a director at Bausch & Lomb sold shares. On the capital allocation front, the Apollo-managed funds disclosed massive, stable stakes in Phoenix Education (69.1%) and Community Health Systems (8.4%), indicating a long-term, hands-off approach. The most critical development is the complete change of control at Abits Group, where the CEO sold his 47% voting stake, creating a binary catalyst tied to a future business acquisition. Overall, the data suggests a market where large institutional players are making strategic bets in small-cap biotech and distressed sectors, while insiders in high-growth and cyclical names are taking profits.

28 high priority 22 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 10, 2026

The 10 filings for the S&P 500 Technology sector, all Form 4 insider transactions, reveal a concentrated wave of insider selling across key cybersecurity, networking, and semiconductor equipment companies. The most significant signal is a massive $26.2M sale by Arista Networks' 10% owner, Andreas Bechtolsheim, which, while executed under a 10b5-1 plan, represents a substantial liquidity event. KLA Corp shows a pattern of multiple executives selling shares, including a $4.31M sale by the EVP and CLO, and routine tax-withholding transactions by the CEO and CFO. Datadog and CrowdStrike also saw insider sales by a director and the CEO, respectively. The aggregate insider activity, particularly the high-value sales and the number of distinct filers, suggests a cautious sentiment among company insiders in the tech sector, potentially signaling a belief that current valuations are at or near peak levels. No period-over-period comparisons, forward-looking guidance, or capital allocation data were available in these filings, limiting the analysis to insider trading patterns.

9 high priority 1 medium 10 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 10, 2026

The August 10, 2026 batch of NASDAQ-100 filings reveals a market dominated by significant capital market activities and divergent insider sentiment. The most material developments are Alphabet's massive $25 billion debt offering, signaling a major capital allocation event, and Strategy Inc's continued aggressive bitcoin treasury management, which shows a shift from accumulation to balance sheet optimization. Insider trading patterns are notably bearish, with a Director at Strategy Inc and the CFO of Netflix executing substantial sales, while Amazon and Amgen insiders engage in neutral transactions (gifts and awards). The CoreWeave 8-K hints at a potentially transformative financing deal, but lacks detail. Overall, the stream points to a market where large-cap tech is levering up for strategic moves, while insiders at high-growth and crypto-exposed names are taking profits. No filings were excluded as all 12 are within the NASDAQ-100 scope.

8 high priority 4 medium 12 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 10, 2026

The August 10, 2026, batch of 50 filings reveals a market dominated by passive institutional adjustments and significant insider de-risking, rather than aggressive new activist campaigns. The most material event is the $1.65 billion capital raise at **UWM Holdings Corp.**, which includes a dilutive rights offering and warrants, signaling severe financial distress despite the company's public denial. Concurrently, the **Innovex International** and **Groupon** filings show major insiders (Amberjack Capital and Pale Fire Capital) executing large-scale sales or option exercises to reduce exposure, creating overhang. On the passive front, major index funds like Vanguard and BlackRock are making minor, likely index-driven adjustments, while specialized funds like Oaktree and Ares are taking concentrated, often distressed positions. The landscape is bifurcated between stable, passive ownership in liquid names and high-conviction, high-risk bets in stressed or special situation equities.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 10, 2026

The five filings in this S&P 500 Financials digest present a bifurcated picture. Berkshire Hathaway’s Q2 2026 results are a clear standout, with net earnings doubling to $25.7B on a 10% revenue rise, driven by $16.1B in investment gains. However, a massive $61.6B swing in investing cash flows and a sharp decline in cash reserves signal a shift from net selling to aggressive deployment into equities, acquisitions ($9.7B in H1 2026 vs. $101M in H1 2025), and record $4.5B in buybacks. In contrast, insider selling at Capital One (minor) and a large $25M block sale by J.P. Morgan’s asset management arm in its private markets fund inject caution into the asset management sub-sector. T. Rowe Price’s crypto ETF remains a non-event, and Progressive's 8-K is purely procedural. The dominant theme is capital rotation—Berkshire is actively recycling its massive cash hoard into yield and growth, while J.P. Morgan’s sell-off may reflect portfolio rebalancing or profit-taking in private market exposure.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 10, 2026

The 14 filings for the S&P 500 Consumer Staples stream are overwhelmingly dominated by routine insider equity awards at Procter & Gamble (PG), indicating a standard compensation cycle with no material trading signals. The only actionable signal comes from Hershey (HSY), where the 10% owner (Hershey Trust) sold ~$1.25M in stock under a 10b5-1 plan, a pre-planned but notable reduction. Archer-Daniels-Midland (ADM) filed a routine 8-K with no new financial data, offering no insights. The period-over-period, forward-looking, and capital allocation enriched data fields are entirely absent from all filings, preventing any trend analysis, guidance assessments, or cross-company comparisons. The key takeaway is a lack of material, actionable intelligence from this batch, with the Hershey insider sale being the sole event warranting attention.

13 high priority 1 medium 14 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 10, 2026

The sole filing in this digest is a Form 4 from Waste Management Inc., reporting a gift of 5,357 shares by EVP & CFO Reed David L., leaving him with 5,357 shares. The transaction is non-market and carries neutral sentiment, indicating no direct signal of management conviction. With only one filing, portfolio-level trend analysis is limited, but the event highlights a potential estate planning or personal liquidity move by a key insider. The absence of market transactions, guidance changes, or capital allocation updates suggests a quiet period for the S&P 500 Industrials stream. Investors should monitor for any subsequent insider sales or changes in executive holdings that could signal a shift in sentiment.

1 high priority 1 total filings
· daily

Insider Trading Pulse — August 10, 2026

The August 10, 2026 insider trading pulse reveals a market with starkly divergent insider conviction. While the day is dominated by a broad wave of bullish insider buying at **Taiwan Semiconductor Manufacturing Co (TSMC)**, with 10 separate executives collectively purchasing shares, signaling strong internal confidence in the company's trajectory, the most significant capital movement is a massive $13.6M sale by the Executive Chair of **Floor & Decor Holdings**, representing a near-total liquidation of his stake. This creates a clear 'risk-on' signal for the semiconductor sector versus a 'risk-off' warning for home improvement retail. Other notable bullish signals include a $6.17M open-market purchase by the CEO of **51Talk Online Education Group** and a $498K buy by the CEO of **PROCEPT BioRobotics**, both indicating deep management conviction. On the bearish side, the CEO of **Karooooo Ltd.** sold $1.19M in stock, and the CEO of **Allot Ltd.** sold $222K, adding to a pattern of insider selling in the tech services space. The data suggests a market where insiders are betting heavily on specific growth stories (semiconductors, education tech, medtech) while reducing exposure to consumer cyclical and certain tech-enabled services.

49 high priority 1 medium 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 10, 2026

The 21 filings for the Dow Jones 30 stream present a mixed picture dominated by routine insider transactions and a few high-impact events. The most critical development is UnitedHealth Group's stellar Q2 2026, where a 61% surge in net earnings and a 55% jump in operating earnings signal a powerful turnaround in medical cost management, despite flat revenue growth. This is a significant outlier compared to the stream's overall lack of major operational updates. Conversely, a $25 billion debt offering by Alphabet Inc. introduces a major capital structure shift, increasing leverage for general corporate purposes. The remaining filings are overwhelmingly routine insider transactions, primarily stock awards at Procter & Gamble and Amgen, which offer limited actionable signals. A notable bearish signal comes from a Merck executive's $644K stock sale, and a large $25M sale by an affiliate of JPMorgan in a private markets fund warrants attention. The period-over-period data from UnitedHealth is the key differentiator, providing the only deep financial trend analysis in this batch, while the rest of the stream is characterized by corporate governance noise rather than fundamental business shifts.

21 high priority 21 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 10, 2026

This digest covers five US SEC filings, all flagged for corporate distress signals. The dominant theme is Nasdaq non-compliance and delisting risk, with three companies (Arcadia Biosciences, Lexaria Bioscience, and Northann Corp.) receiving explicit notices. A fourth, Construction Partners, faces a governance-related compliance issue. The fifth, Faraday Future, has resolved its bid price deficiency but remains in a precarious financial state. Period-over-period comparisons were largely absent from these filings, limiting trend analysis; however, the filings reveal a severe lack of liquidity and governance failures. The most critical development is the absence of remediation plans from Lexaria and Northann, suggesting a high probability of actual delisting. The market implications are significant: investors face potential total losses in companies unable to cure deficiencies, while others may see dilution from reverse stock splits. A portfolio-level pattern is the concentration of distress in micro-cap and pre-revenue companies, where cash burn and governance lapses are acute.

5 high priority 5 total filings
· daily

US SEC Filings Daily Market Digest — August 10, 2026

The August 10, 2026, filing set reveals a mixed market landscape with notable divergences across sectors. Key themes include robust revenue growth in technology and aerospace, contrasted with margin compression and losses in healthcare and emerging tech. RadNet and Embraer stand out with strong operational performance and upward guidance revisions, signaling confidence in their respective markets. Conversely, AirSculpt Technologies and IonQ report widening losses despite revenue growth, highlighting challenges in scaling profitability. Insider activity is sparse, but capital allocation trends show a focus on reinvestment over shareholder returns. The most critical developments are Embraer's doubled free cash flow guidance and RadNet's record revenue, which have significant market implications for aerospace and diagnostic imaging sectors. Portfolio-level patterns indicate a bifurcation between established industrial and tech firms executing well versus growth companies facing profitability pressures.

9 high priority 41 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 10, 2026

Today's filings in the S&P 500 Consumer Discretionary sector are dominated by insider transactions, revealing a mixed but cautious sentiment among top executives. Director Fang Andy of DoorDash executed a planned sale of $3.23M in stock, while AutoZone's Sr. VP LeRiche Dennis W. realized a significant profit of ~$2.97M on a same-day option exercise and sale. In contrast, Amazon's CEO of Worldwide Stores, Herrington Douglas J., made a gift of 22,000 shares, a neutral signal often used for estate planning. NIKE announced a key executive transition with its VP and CAO resigning, adding a layer of operational uncertainty. The absence of forward-looking guidance or capital allocation changes across these filings suggests a period of relative stability, with insider activity providing the primary actionable intelligence for the day.

5 high priority 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 10, 2026

The nine filings from the S&P 500 Healthcare sector on August 10, 2026, reveal a bifurcated landscape. UnitedHealth Group stands out with a powerful operational turnaround, reporting a 61% surge in net earnings and a 55% jump in operating earnings, driven by a 4.1% reduction in medical costs, signaling strong managed care execution. In stark contrast, a wave of insider selling at Thermo Fisher Scientific, Merck, and Intuitive Surgical creates a bearish undercurrent, with executives liquidating significant holdings, often via 10b5-1 plans. The sector is characterized by a divergence between a dominant managed care player showing robust financial health and a cluster of life sciences and med-tech companies where insider sentiment is cautious. Capital allocation trends are mixed, with UnitedHealth aggressively returning capital via buybacks and dividends, while others show no such activity. The primary themes are operational efficiency versus insider skepticism, making UnitedHealth a clear standout for bullish investors, while the insider sales at other names warrant close monitoring for potential headwinds.

9 high priority 9 total filings